Autoantibody negativity and autoimmune hepatitis severity
Treatments studied
Part of Digestive system, Immune system & allergy clinical trials.
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have autoimmune hepatitis (AIH) and are being treated with medications that suppress your immune system
- You are being followed at Hôpital Saint-Antoine or in Guadeloupe as part of a specific liver disease network
- You are covered by French social security
- You can give written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines the molecular profile of autoimmune hepatitis (a liver condition where the immune system attacks liver cells) using lipid analysis. Researchers hope to better understand the disease and potentially improve diagnosis and treatment in the future.
This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.
This is a research study collecting information and blood samples from patients with autoimmune hepatitis (a condition where the immune system attacks the liver) and patients with other types of liver disease. The goal is to better understand how these diseases develop and find new ways to diagnose and treat them.
This study is looking at specific immune cells (T cells) in the blood of people with autoimmune hepatitis (AIH) to better understand the disease. If you have untreated AIH and meet certain criteria, you may be able to participate.
This study looks at factors that help predict how well people with autoimmune hepatitis respond to treatment. It is for patients who are newly diagnosed or have not had treatment for at least 3 months, and who have had a liver biopsy to confirm the diagnosis.
This study looks at how well a scoring system can predict whether steroids will work in people with a severe, sudden autoimmune liver inflammation. If you qualify, your doctors may use your test results to estimate the chance steroids will help and compare that estimate to real outcomes.
Hear when a new Auto-immune Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.